Tendonitis Treatment Market to be dominated by Automatic Device through 2028
The
increasing number of sport-related injuries is expected to drive the Global
Tendonitis Treatment Market in the forecast period, 2024-2028.
According to
TechSci Research report, “Tendonitis Treatment Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global
tendonitis treatment market is anticipated to grow at an impressive rate in the
forecast period, 2024-2028. This can be ascribed to the rising prevalence of
bone-related disorders like arthritis also diabetes along with the enhancement
of novel technologies, and therapies for the treatment of tendonitis across the
globe. Similarly, increased funding from government organizations for the development
of healthcare infrastructure and other large investments by some big
corporations in the medical field, will
boost the growth of opportunities in the market, in the forecast period.
Additionally, the increasing number of older population across the globe and
development of better healthcare for the treatment of bone related injuries is
further expected to increase the demand for the tendonitis treatment market
during the forecast period. Similarly, a major population is inclined toward
noninvasive therapies or surgeries for the treatment of bone injuries with
sudden injuries due to trauma is expected to create lucrative growth during the
forecast period. Besides, due to not maintain healthy lifestyle such as
repetitive forces, such as those caused by running, can cause stress fractures
of the foot, ankle, tibia, or hip, trauma, falls from height, motor vehicle
accidents are the main factors which will boost the growth of the market during
the forecast period.
However,
increasing side effects associated with treatments and the recurrent nature of
the injuries, may hamper the global tendonitis treatment market in the forecast
period. Similarly, ineffective and less prompt treatments combined with a lack
of efficacy related to treatments, can restrict the growth of the global
tendonitis treatment market in the forecast period. Additionally, travel
restrictions due to the pandemic and increased infection load in the medical
sector can restrict the growth of the market during the forecast period.
Browse over XX
market data Figures spread through 110 Pages and an in-depth TOC on "Tendonitis Treatment Market"
The Global
Tendonitis Treatment market is segmented by therapy, by condition and by
region.
Based on
Condition, the global tendonitis treatment market can be segmented into Tennis
Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, and Others. The
tennis elbow segment is expected to
dominate the market in 2022 and maintain its dominance throughout the forecast
period. The increasing prevalence of lateral elbow tendinopathy and medial
elbow tendinopathy across the globe along with the growing aging population is
expected to boost the market growth during the forecast period. Similarly,
increasing demand for lifestyle changes with some physical activity ,which can
include different sports activities causing
injuries, will further propel the market in the forecast period.
Based on
Therapy, the global tendonitis treatment market can be divided into Therapy and
Surgery. The surgery segment is expected to dominate the market in 2022 and
maintain its dominance throughout the forecast period. This can be ascribed to
increasing sport-related injuries with increasing demand for sports activities
across the globe. Similarly, the increasing demand for maintaining a healthy
lifestyle is also propelling the growth of the market. Also, the growing demand
for minimally invasive surgeries for the treatment of tendonitis is expected to
create significant growth during the forecast period.
Major companies
operating in the global tendonitis treatment market are:
- Merck and Co. Inc.
- Bayer AG
- AstraZeneca Plc.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Abbott Laboratories, Inc.
- Pfizer, Inc.
- GlaxoSmithKline PLC
- Almatica Pharma, Inc.
In March
2017,RepliCel OLife Sciences completed the phase I human clinical study of
RCT-01, a cell therapy for the treatment of patients with injured Achiles
tendon. An exoskeleton knee brace that is about 30% lighter than standard
models was developed by Delsson, a Singapore-based engineering firm, in
partnership with 3D printing experts at Nanyang Technological University (NTU)
in Singapore, in December 2021.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North America is
expected to register the highest growth in the global tendonitis treatment market on
account of increasing collaboration between pharmaceutical companies to develop
new therapies for the treatment of bone-related injuries across the region.
Similarly, the growing government funds for research and development of bone
disorder in the healthcare sector along with the rapid adoption of new therapies
can further propel the market growth during the forecast period. Additionally,
the growing aging population pool susceptible for bone injuries due to
osteoporosis, arthritis along with constantly improving healthcare
infrastructure is expected to drive the demand for the tendonitis treatment market
in the forecast period. Similarly, the growing industry
of medical tourism is expected to propel the market
growth till 2028” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Global
Tendonitis
Treatment Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Therapy
(Therapy v/s Surgery), By Condition (Tennis Elbow,
Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others) and By Region”, has evaluated
the future growth potential of the global tendonitis treatment market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision-makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the global tendonitis treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com